| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/04/2013 | WO2013101014A2 High pressure treatment of aggregated interferons |
| 07/04/2013 | WO2013100721A1 Novel antibacterial and fungicidal peptide in which lysine and tryptophan residues are repeated four times, and use thereof |
| 07/04/2013 | WO2013100704A1 A site-specific glp-2 conjugate using an immunoglobulin fragment |
| 07/04/2013 | WO2013100580A1 Novel fusion protein binding to wnt |
| 07/04/2013 | WO2013098743A1 Composition for a medical device or for a cosmetic or pharmaceutical preparation comprising a decapeptide derived from deinococcus radiodurans |
| 07/04/2013 | WO2013098672A2 Alpha1-proteinase inhibitor for delaying the onset or progression of pulmonary exacerbations |
| 07/04/2013 | WO2013098415A1 Preparation for improving memory and learning and use thereof |
| 07/04/2013 | WO2013098372A1 Subcutaneous therapeutic use of dpp-4 inhibitor |
| 07/04/2013 | WO2013098339A1 Anti-tumor adjuvant therapy |
| 07/04/2013 | WO2013098337A1 Cell-penetrating peptides |
| 07/04/2013 | WO2013066374A3 Humanin protection of dopaminergic neurons |
| 07/04/2013 | WO2013059778A3 Antigen presenting cancer vaccine with gamma interferon |
| 07/04/2013 | WO2013055073A3 Ophthalmic composition containing cyclosporine and method for preparing same |
| 07/04/2013 | WO2013048211A3 Apoptosis-inducing composition comprising kaiso protein |
| 07/04/2013 | WO2013041663A3 Modified apidaecin derivatives as antibiotic peptides |
| 07/04/2013 | WO2013039373A3 Dialysed extract of leucocytes from shark spleen, for obtaining a transfer factor with increased potential, and method for extracting, checking and counting same |
| 07/04/2013 | WO2013036904A3 Methods, agents and peptides for inhibiting matrix metalloproteinase-2 signaling |
| 07/04/2013 | WO2013036778A3 Compstatin analogs with improved pharmacokinetic properties |
| 07/04/2013 | WO2013032828A8 Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking |
| 07/04/2013 | US20130174286 In Vivo Gene Silencing By Chemically Modified and Stable siRNA |
| 07/04/2013 | US20130172656 Novel use of armillaridin for treating cancer |
| 07/04/2013 | US20130172528 Dalbavancin compositions for treatment of bacterial infections |
| 07/04/2013 | US20130172403 Gene therapy for sulfatase deficiency |
| 07/04/2013 | US20130172300 New hormonal composition and its use |
| 07/04/2013 | US20130172275 Inhibiting binding of fgf23 to the binary fgfr-klotho complex for the treatment of hypophosphatemia |
| 07/04/2013 | US20130172271 Pharmaceutical Spray Drying |
| 07/04/2013 | US20130172269 Lyophilized recombinant vwf formulations |
| 07/04/2013 | US20130172267 Use of cyclic depsipeptides to inhibit kallikrein 7 |
| 07/04/2013 | US20130172263 Vh4 codon signature for multiple sclerosis |
| 07/04/2013 | US20130172260 Prevention of indwelling device related infection: composition and methods |
| 07/04/2013 | US20130172259 Modified vitamin k-dependent polypeptides |
| 07/04/2013 | US20130172257 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 07/04/2013 | US20130172256 Method of treating diabetes-related impaired wound healing |
| 07/04/2013 | US20130172255 Compositions and methods for treating joints |
| 07/04/2013 | US20130172253 Method of diagnosing and treating oxidative stress-impaired wound healing |
| 07/04/2013 | US20130172252 Methods for promoting hair growth |
| 07/04/2013 | US20130172251 Modified ghrelin peptides |
| 07/04/2013 | US20130172250 Exendins To Lower Cholesterol And Triglycerides |
| 07/04/2013 | US20130172248 3-[4-(phenylaminooxalylamino)phenyl]hex-4-ynoic acids, process for preparation thereof and use thereof as a medicament |
| 07/04/2013 | US20130172246 Insulin glargine versus metformin for the first-line treatment of early type-2 diabetes |
| 07/04/2013 | US20130172244 Subcutaneous therapeutic use of dpp-4 inhibitor |
| 07/04/2013 | US20130172243 Methods for Treating Diabetes and Reducing Body Weight |
| 07/04/2013 | US20130172241 Method for processing prolamin-containing feed for a ruminant animal to potentiate milk production or conception |
| 07/04/2013 | US20130172240 Methods for treating hcv |
| 07/04/2013 | US20130172239 Solid compositions |
| 07/04/2013 | US20130172237 Methods of treatment using single doses of oritavancin |
| 07/04/2013 | US20130172236 Methods for extracting platelets and compositions obtained therefrom |
| 07/04/2013 | US20130172235 Oral treatment of inflammatory bowel disease |
| 07/04/2013 | US20130171726 Multiple promoter expression cassettes for simultaneous delivery of rnai agents |
| 07/04/2013 | US20130171279 Composition for Reducing Side- and After-Effects of Cancer Treatment |
| 07/04/2013 | US20130171252 Formulation Comprising a Type B Lantibiotic |
| 07/04/2013 | US20130171246 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 07/04/2013 | US20130171245 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 07/04/2013 | US20130171244 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 07/04/2013 | US20130171243 Octreotide-modified nanomedicine for cancer treatment or cancer palliative care |
| 07/04/2013 | US20130171236 Prevention and Treatment of Ischemia-Reperfusion Injury and Related Conditions |
| 07/04/2013 | US20130171223 Super-saturating delivery vehicles for poorly water-soluble pharmaceutical and cosmetic active ingredients and supression of crystallization of pharmaceutical active incredients |
| 07/04/2013 | US20130171217 Enzymatic peracid generation for use in skin care products |
| 07/04/2013 | US20130171211 Methods and uses for inhibiting platelet coagulation |
| 07/04/2013 | US20130171210 Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications |
| 07/04/2013 | US20130171209 Reducing post-operative adhesion formation with intraperitoneal glutamine |
| 07/04/2013 | US20130171205 Nanocell Drug Delivery System |
| 07/04/2013 | US20130171194 STABLE FORMULATIONS OF NEISSERIA MENINGITIDIS rLP2086 ANTIGENS |
| 07/04/2013 | US20130171187 Glucan-based vaccines |
| 07/04/2013 | US20130171173 Method for prongf assay for in vitro diagnosis of cancer in particular breast, thyroid or lung cancer and therapeutic use of prongf |
| 07/04/2013 | US20130171172 Calpain-3 inhibitors for treating muscular dystrophies and cardiomyopathies |
| 07/04/2013 | US20130171162 Compositions and methods for the prevention of oxidative degradation of proteins |
| 07/04/2013 | US20130171159 Phosphorylated twist1 and metastasis |
| 07/04/2013 | US20130171158 Treatment of abnormalities of glucose metabolism with an antagonist of inhibitor of differentiation 1 |
| 07/04/2013 | US20130171157 NOGO Receptor-Mediated Blockade of Axonal Growth |
| 07/04/2013 | US20130171156 BMP-1 Procollagen C-Proteinase for Diagnosis and Treatment of Bone and Soft Tissue Defects and Disorders |
| 07/04/2013 | US20130171141 Combination of hdac inhibitors with thrombocytopenia drugs |
| 07/04/2013 | US20130171139 Ncam-vase and neurodegeneration |
| 07/04/2013 | US20130171136 Methods of Treating Giant Cell Arteritis With Anti-TNF Alpha Antibodies |
| 07/04/2013 | US20130171130 Soluble interleukin-20 receptor |
| 07/04/2013 | US20130171127 Composition for regenerating normal tissue from fibrotic tissue |
| 07/04/2013 | US20130171124 Compositions And Methods Of Treating Head And Neck Cancer |
| 07/04/2013 | US20130171122 Endopeptidase and neurotoxin combination treatment of bladder disorders |
| 07/04/2013 | US20130171121 Maturation of gastrointestinal tract |
| 07/04/2013 | US20130171105 Cancer therapy using a combination of a hsp90 inhibitory compound and a topoisomerase ii inhibitor |
| 07/04/2013 | US20130171104 Synergistic activity of modulators of the no metabolism and of nadph oxidase in the sensitization of tumor cells |
| 07/04/2013 | US20130171103 Methods for treating viral conditions |
| 07/04/2013 | US20130171102 Heterocyclic flaviviridae virus inhibitors |
| 07/04/2013 | US20130171101 3-amino-2-(4-nitrophenyl)-4-(3H)-quinazolinone or derivatives thereof for treating or preventing antiviral infections |
| 07/04/2013 | US20130171097 Method for the prophylactic or therapeutic treatment of glucocorticoid-induced osteoporosis |
| 07/04/2013 | US20130171096 Immunobinders directed against sclerostin |
| 07/04/2013 | US20130171091 Nanocell Drug Delivery System |
| 07/04/2013 | US20130171090 Methods of treating hepatic encephalopathy |
| 07/04/2013 | US20130171079 Composition to stabilise kojic acid |
| 07/04/2013 | US20130171073 Treatment of pituitary corticotroph tumors using r-roscovitine |
| 07/04/2013 | US20130171069 Neurotoxic target for amylospheroid, method and material for reducing the neurotoxicity of amylospheroid, and use thereof |
| 07/04/2013 | CA2844878A1 Alpha1-proteinase inhibitor for delaying the onset or progression of pulmonary exacerbations |
| 07/03/2013 | EP2610619A1 Hemokinin-1 receptor and hemokinin-1-derived peptide |
| 07/03/2013 | EP2610349A1 Whole egg protein peptides, preparation method and use thereof |
| 07/03/2013 | EP2610265A1 Glut-1 as a receptor for HTLV envelopes and its uses |
| 07/03/2013 | EP2609930A2 Treatments for neurological disorders |
| 07/03/2013 | EP2608808A2 Treatment for neoplastic diseases |
| 07/03/2013 | EP2608802A2 Immunotherapeutic method for treating prostate cancer |
| 07/03/2013 | EP2608801A2 INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF TYROSYL-tRNA SYNTHETASES |
| 07/03/2013 | EP2608800A2 Compositions and uses of materials with high antimicrobial activity and low toxicity |